2020 ATS/ERS/ESCMID/IDSA临床实践指南:非结核分枝杆菌性肺病的治疗

2020-07-06 美国胸科学会 Clin Infect Dis . 2020 Jul 6;

2020年7月,美国胸科学会(ATS)联合欧洲呼吸学会(ERS)等多家学会组织共同发布了非结核分枝杆菌性肺病的治疗指南。非结核分枝杆菌(NTM)有超过190种和亚种,其中一些能在所有年龄段人群中引发疾

中文标题:

2020 ATS/ERS/ESCMID/IDSA临床实践指南:非结核分枝杆菌性肺病的治疗

英文标题:

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary

发布机构:

美国胸科学会

发布日期:

2020-07-06

简要介绍:

2020年7月,美国胸科学会(ATS)联合欧洲呼吸学会(ERS)等多家学会组织共同发布了非结核分枝杆菌性肺病的治疗指南。非结核分枝杆菌(NTM)有超过190种和亚种,其中一些能在所有年龄段人群中引发疾病并影响肺和肺外器官。本文主要聚焦成人非结核分枝杆菌性肺病的治疗,共针对22个PICO问题提出指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 ATS_ERS_ESCMID_IDSA临床实践指南:非结核分枝杆菌性肺病的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=51edb1c0019a0264, title=2020 ATS/ERS/ESCMID/IDSA临床实践指南:非结核分枝杆菌性肺病的治疗, enTitle=Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary, guiderFrom=Clin Infect Dis . 2020 Jul 6;, authorId=0, author=, summary=2020年7月,美国胸科学会(ATS)联合欧洲呼吸学会(ERS)等多家学会组织共同发布了非结核分枝杆菌性肺病的治疗指南。非结核分枝杆菌(NTM)有超过190种和亚种,其中一些能在所有年龄段人群中引发疾, cover=https://img.medsci.cn/2020726/1595778954342_2020535.jpg, journalId=0, articlesId=null, associationId=181, associationName=美国胸科学会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Jul 06 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年7月,美国胸科学会(ATS)联合欧洲呼吸学会(ERS)等多家学会组织共同发布了非结核分枝杆菌性肺病的治疗指南。非结核分枝杆菌(NTM)有超过190种和亚种,其中一些能在所有年龄段人群中引发疾病并影响肺和肺外器官。本文主要聚焦成人非结核分枝杆菌性肺病的治疗,共针对22个PICO问题提出指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=50206, tagName=非结核分枝杆菌)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=50206, guiderKeyword=非结核分枝杆菌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4158, appHits=320, showAppHits=0, pcHits=1035, showPcHits=3837, likes=4, shares=16, comments=11, approvalStatus=1, publishedTime=Mon Jul 27 00:11:20 CST 2020, publishedTimeString=2020-07-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 26 23:56:04 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 20:15:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ATS_ERS_ESCMID_IDSA临床实践指南:非结核分枝杆菌性肺病的治疗.pdf)])
2020 ATS_ERS_ESCMID_IDSA临床实践指南:非结核分枝杆菌性肺病的治疗.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241172, encodeId=67fd12411e294, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6dd6328823, createdName=1054371_3882, createdTime=Fri Aug 26 15:36:59 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054333, encodeId=8588105433313, content=非常好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Fri Sep 24 06:29:42 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053544, encodeId=8108105354492, content=看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44735612389, createdName=ms3000000558868435, createdTime=Tue Sep 21 18:27:23 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976277, encodeId=61979e6277f4, content= 下载看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eb71631578, createdName=gagaya, createdTime=Wed Jun 23 18:23:47 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894654, encodeId=394d894654ba, content=还是要加强英语学习,看不懂。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/93eb729b5e18b358217d152cda095c48.jpg, createdBy=f4c42215305, createdName=l x w, createdTime=Mon Oct 26 22:52:40 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2022-08-26 1054371_3882

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1241172, encodeId=67fd12411e294, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6dd6328823, createdName=1054371_3882, createdTime=Fri Aug 26 15:36:59 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054333, encodeId=8588105433313, content=非常好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Fri Sep 24 06:29:42 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053544, encodeId=8108105354492, content=看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44735612389, createdName=ms3000000558868435, createdTime=Tue Sep 21 18:27:23 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976277, encodeId=61979e6277f4, content= 下载看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eb71631578, createdName=gagaya, createdTime=Wed Jun 23 18:23:47 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894654, encodeId=394d894654ba, content=还是要加强英语学习,看不懂。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/93eb729b5e18b358217d152cda095c48.jpg, createdBy=f4c42215305, createdName=l x w, createdTime=Mon Oct 26 22:52:40 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2021-09-24 王隽ms6000000074992777

    非常好的指南

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1241172, encodeId=67fd12411e294, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6dd6328823, createdName=1054371_3882, createdTime=Fri Aug 26 15:36:59 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054333, encodeId=8588105433313, content=非常好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Fri Sep 24 06:29:42 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053544, encodeId=8108105354492, content=看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44735612389, createdName=ms3000000558868435, createdTime=Tue Sep 21 18:27:23 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976277, encodeId=61979e6277f4, content= 下载看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eb71631578, createdName=gagaya, createdTime=Wed Jun 23 18:23:47 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894654, encodeId=394d894654ba, content=还是要加强英语学习,看不懂。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/93eb729b5e18b358217d152cda095c48.jpg, createdBy=f4c42215305, createdName=l x w, createdTime=Mon Oct 26 22:52:40 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2021-09-21 ms3000000558868435

    看不懂

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1241172, encodeId=67fd12411e294, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6dd6328823, createdName=1054371_3882, createdTime=Fri Aug 26 15:36:59 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054333, encodeId=8588105433313, content=非常好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Fri Sep 24 06:29:42 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053544, encodeId=8108105354492, content=看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44735612389, createdName=ms3000000558868435, createdTime=Tue Sep 21 18:27:23 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976277, encodeId=61979e6277f4, content= 下载看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eb71631578, createdName=gagaya, createdTime=Wed Jun 23 18:23:47 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894654, encodeId=394d894654ba, content=还是要加强英语学习,看不懂。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/93eb729b5e18b358217d152cda095c48.jpg, createdBy=f4c42215305, createdName=l x w, createdTime=Mon Oct 26 22:52:40 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2021-06-23 gagaya

    下载看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1241172, encodeId=67fd12411e294, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6dd6328823, createdName=1054371_3882, createdTime=Fri Aug 26 15:36:59 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054333, encodeId=8588105433313, content=非常好的指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a355480258, createdName=王隽ms6000000074992777, createdTime=Fri Sep 24 06:29:42 CST 2021, time=2021-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053544, encodeId=8108105354492, content=看不懂, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44735612389, createdName=ms3000000558868435, createdTime=Tue Sep 21 18:27:23 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976277, encodeId=61979e6277f4, content= 下载看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0eb71631578, createdName=gagaya, createdTime=Wed Jun 23 18:23:47 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894654, encodeId=394d894654ba, content=还是要加强英语学习,看不懂。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/93eb729b5e18b358217d152cda095c48.jpg, createdBy=f4c42215305, createdName=l x w, createdTime=Mon Oct 26 22:52:40 CST 2020, time=2020-10-26, status=1, ipAttribution=)]
    2020-10-26 l x w

    还是要加强英语学习,看不懂。

    0

拓展阅读

2016 非结核分枝杆菌病实验室诊断专家共识

中华医学会结核病学分会 · 2016-06-30

非结核分枝杆菌肺病影像诊断专家共识

中国研究型医院学会(CRHA,Chinese Research Hospital Association) · 2021-06-15

2023 IPOG共识指南:非结核分枝杆菌颈面部淋巴结炎的诊断和管理

国际小儿耳鼻喉科小组(IPOG,International Pediatric Otolaryngology Group) · 2023-02-02

FDA 指南:非结核分枝杆菌引起的肺部疾病的开发治疗药物

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2023-08-31